Lulizumab
Product Specifications
CAS Number
2235419-62-0
Target
Immunology/Inflammation related
Related Pathways
Immunology/Inflammation
Bioactivity
Lulizumab, a humanized anti-CD28 recombinant antibody, functions as a selective CD28 blockade. By specifically targeting CD28 signaling, it inhibits T cell activation [1].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/64416316517253387/T76817
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1202322-01 0.02 mg (E-Coli)
Recombinant Ctenopharyngodon idella Actin, cytoplasmic 1 (actb)
Ask
View Details 
MBS1202322-02 0.02 mg (Yeast)
Recombinant Ctenopharyngodon idella Actin, cytoplasmic 1 (actb)
Ask
View Details MBS1202322-03 0.1 mg (E-Coli)
Recombinant Ctenopharyngodon idella Actin, cytoplasmic 1 (actb)
Ask
View Details 
MBS1202322-04 0.1 mg (Yeast)
Recombinant Ctenopharyngodon idella Actin, cytoplasmic 1 (actb)
Ask
View Details MBS1202322-05 0.02 mg (Baculovirus)
Recombinant Ctenopharyngodon idella Actin, cytoplasmic 1 (actb)
Ask
View Details